Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Gain (Loss) on Disposition of Assets

2.5 / 5 stars · 60/120 Roast Me

Amphastar Pharmaceuticals, Inc. Gain (Loss) on Disposition of Assets

Amphastar Pharmaceuticals, Inc. (AMPH) reported Gain (Loss) on Disposition of Assets of -$13.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Other Income

us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-06

  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was -$9.00K.
  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was -$4.00K.
  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was -$6.00K, a 105.94% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was -$1.00K.
  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for fiscal 2025 was -$39.00K.
  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for fiscal 2024 was -$9.00K.
  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for fiscal 2023 was -$475.00K.
  • Amphastar Pharmaceuticals, Inc. gain (loss) on disposition of assets for fiscal 2022 was -$141.00K.
Period endGain (Loss) on Disposition of Assets 3 monthGain (Loss) on Disposition of Assets 6 monthGain (Loss) on Disposition of Assets 9 monthGain (Loss) on Disposition of Assets 12 month
2026-06-30-$9.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$13.00K
10-Q · filed 2026-08-06
-$19.00K
derived: sum of 3 quarters · filed 2026-08-06
-$20.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$4.00K
10-Q · filed 2026-05-07
-$10.00K
derived: sum of 2 quarters · filed 2026-05-07
-$11.00K
derived: sum of 3 quarters · filed 2026-05-07
-$41.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$7.00K
derived: sum of 2 quarters · filed 2026-02-26
-$37.00K
derived: sum of 3 quarters · filed 2026-08-06
-$39.00K
10-K · filed 2026-02-26
2025-09-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$31.00K
derived: sum of 2 quarters · filed 2026-08-06
-$33.00K
10-Q · filed 2025-11-06
$68.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$30.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$32.00K
10-Q · filed 2026-08-06
$69.00K
derived: sum of 3 quarters · filed 2026-08-06
$67.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$2.00K
10-Q · filed 2026-05-07
$99.00K
derived: sum of 2 quarters · filed 2026-05-07
$97.00K
derived: sum of 3 quarters · filed 2026-05-07
2024-12-31$101.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$99.00K
derived: sum of 2 quarters · filed 2026-02-26
-$9.00K
10-K · filed 2026-02-26
2024-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$110.00K
10-Q · filed 2025-11-06
2024-06-30-$108.00K
10-Q · filed 2025-08-07
2023-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$468.00K
derived: sum of 2 quarters · filed 2026-02-26
-$473.00K
derived: sum of 3 quarters · filed 2026-02-26
-$475.00K
10-K · filed 2026-02-26
2023-09-30-$467.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$472.00K
derived: sum of 2 quarters · filed 2024-11-07
-$474.00K
10-Q · filed 2024-11-07
-$667.00K
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30-$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$7.00K
10-Q · filed 2024-08-09
-$200.00K
derived: sum of 3 quarters · filed 2025-03-03
-$206.00K
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31-$2.00K
10-Q · filed 2024-05-10
-$195.00K
derived: sum of 2 quarters · filed 2025-03-03
-$201.00K
derived: sum of 3 quarters · filed 2025-03-03
-$142.00K
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31-$193.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$199.00K
derived: sum of 2 quarters · filed 2025-03-03
-$140.00K
derived: sum of 3 quarters · filed 2025-03-03
-$141.00K
10-K · filed 2025-03-03
2022-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$53.00K
derived: sum of 2 quarters · filed 2023-11-08
$52.00K
10-Q · filed 2023-11-08
$42.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$59.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$58.00K
10-Q · filed 2023-08-09
$48.00K
derived: sum of 3 quarters · filed 2024-02-29
$24.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$1.00K
10-Q · filed 2023-05-09
-$11.00K
derived: sum of 2 quarters · filed 2024-02-29
-$35.00K
derived: sum of 3 quarters · filed 2024-02-29
-$343.00K
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$34.00K
derived: sum of 2 quarters · filed 2024-02-29
-$342.00K
derived: sum of 3 quarters · filed 2024-02-29
-$348.00K
10-K · filed 2024-02-29
2021-09-30-$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$332.00K
derived: sum of 2 quarters · filed 2022-11-08
-$338.00K
10-Q · filed 2022-11-08
-$417.00K
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$308.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$314.00K
10-Q · filed 2022-08-09
-$393.00K
derived: sum of 3 quarters · filed 2023-03-01
-$524.00K
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$6.00K
10-Q · filed 2022-05-10
-$85.00K
derived: sum of 2 quarters · filed 2023-03-01
-$216.00K
derived: sum of 3 quarters · filed 2023-03-01
-$232.00K
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$79.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$210.00K
derived: sum of 2 quarters · filed 2023-03-01
-$226.00K
derived: sum of 3 quarters · filed 2023-03-01
-$240.00K
10-K · filed 2023-03-01
2020-09-30-$131.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$147.00K
derived: sum of 2 quarters · filed 2021-11-09
-$161.00K
10-Q · filed 2021-11-09
-$328.00K
derived: sum of 4 quarters · filed 2022-03-11
2020-06-30-$16.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$30.00K
10-Q · filed 2021-08-09
-$197.00K
derived: sum of 3 quarters · filed 2022-03-11
-$216.00K
derived: sum of 4 quarters · filed 2022-03-11
2020-03-31-$14.00K
10-Q · filed 2021-05-07
-$181.00K
derived: sum of 2 quarters · filed 2022-03-11
-$200.00K
derived: sum of 3 quarters · filed 2022-03-11
-$245.00K
derived: sum of 4 quarters · filed 2022-03-11
2019-12-31-$167.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$186.00K
derived: sum of 2 quarters · filed 2022-03-11
-$231.00K
derived: sum of 3 quarters · filed 2022-03-11
-$1.04M
10-K · filed 2022-03-11
2019-09-30-$19.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$64.00K
derived: sum of 2 quarters · filed 2020-11-06
-$869.00K
10-Q · filed 2020-11-06
-$1.91M
derived: sum of 4 quarters · filed 2021-03-15
2019-06-30-$45.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$850.00K
10-Q · filed 2020-08-07
-$1.89M
derived: sum of 3 quarters · filed 2021-03-15
-$1.54M
derived: sum of 4 quarters · filed 2021-03-15
2019-03-31-$805.00K
10-Q · filed 2020-05-11
-$1.84M
derived: sum of 2 quarters · filed 2021-03-15
-$1.49M
derived: sum of 3 quarters · filed 2021-03-15
-$1.64M
derived: sum of 4 quarters · filed 2021-03-15
2018-12-31-$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$686.00K
derived: sum of 2 quarters · filed 2021-03-15
-$831.00K
derived: sum of 3 quarters · filed 2021-03-15
-$1.43M
10-K · filed 2021-03-15
2018-09-30$353.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$208.00K
derived: sum of 2 quarters · filed 2019-11-08
-$390.00K
10-Q · filed 2019-11-08
2018-06-30-$145.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$743.00K
10-Q · filed 2019-08-09
2018-03-31-$598.00K
10-Q · filed 2019-05-10
2017-12-31$2.34M
10-K · filed 2020-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87